title: Differential short-term distribution of estrone and oleoyl-estrone administered in liposomes to lean and obese Zucker rats.
abstract: Thirteen-week-old female Zucker lean (Fa/Fa) and obese (fa/fa) rats were injected through a cannula inserted in the left jugular vein with 1 mL/kg of 3H-labeled oleoyl-estrone in liposomes (Merlin-2) (i.e., 670 fmol, 84 kBq). The rats were killed 10 minutes later and dissected. The presence of intact or hydrolyzed oleoyl-estrone was later determined in all samples. The pattern of distribution of estrone was quite different from that of oleoyl-estrone both in rats that were lean and in those that were obese. Estrone was better retained by white adipose tissue than oleoyl-estrone. Liver, spleen, and lungs accumulated more oleoyl-estrone and split part of it, from 4.7% (lung, obese) to 27% (liver, lean). The overall high retention of estrone by the rat tissues results in its very low circulating levels. The fast splitting of liposome-carried oleoyl-estrone by most tissues (up to more than 67% by intestine and skin of lean rats) may help explain the rise in blood free estrone. The differences between lean and obese Zucker rats are mainly quantitative in the case of estrone, the main differences being found in blood and adipose tissues. However, when we compare the data for oleoyl-estrone, the differences cannot be dismissed simply as due to differences in body size or the extent of fat deposits. A large portion of the label remained in the blood of the rats that were obese but not in those that were lean, the tissues of which took up more label. Brown adipose tissue shows a fair affinity for oleoyl-estrone in the rats that were lean but practically does not retain label in the rats that were obese, suggesting that oleoyl-estrone may have a direct effect on brown adipose tissue. The decreased uptake of oleoyl-estrone in rats that were obese shows that the mechanism regulating the turnover or disposal of this signal is altered in this type of genetic obesity.
authors.affiliation: Centre d'Investigació, Laboratoris SALVAT, SA, Esplugues de Llobregat, Spain.
authors.forename: F
authors.initials: F
authors.lastname: Balada
authors.forename: D
authors.initials: D
authors.lastname: Sanchis
authors.forename: M M
authors.initials: MM
authors.lastname: Grasa
authors.forename: J
authors.initials: J
authors.lastname: Virgili
authors.forename: J
authors.initials: J
authors.lastname: Estruch
authors.forename: J A
authors.initials: JA
authors.lastname: Fernández-López
authors.forename: X
authors.initials: X
authors.lastname: Remesar
authors.forename: M
authors.initials: M
authors.lastname: Alemany
mesh_terms: D000273:Adipose Tissue / Q000378:metabolism; D000818:Animals; D004970:Estrone / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000493:pharmacokinetics*; D005260:Female; D008081:Liposomes; D008099:Liver / Q000378:metabolism; D008168:Lung / Q000378:metabolism; D009132:Muscles / Q000378:metabolism; D009765:Obesity / Q000378:metabolism*; D009829:Oleic Acids / Q000008:administration & dosage / Q000493:pharmacokinetics*; D051381:Rats; D011924:Rats, Zucker; D013154:Spleen / Q000378:metabolism; D014018:Tissue Distribution
chemical_list: D008081:Liposomes; D009829:Oleic Acids; D004970:Estrone; C108709:oleoyl-estrone